Will bring on-campus oncology services under one roof
Award-winning, comprehensive solution for upright particle therapy
Only 0.3% of Black cancer patients received proton therapy, compared to 0.5% of white patients
AdventHealth Shawnee Mission appoints president and CEO
For improving dose delivery, image guidance is a clear priority
Will create AI models for organ segmentation to support cancer treatment
May be a desirable alternative to more aggressive treatments
Will develop standardized MR protocols to improve quantitative imaging
With funding, the DOE could have most of it operational within two years
Will compare proton therapy to photon radiotherapy, chemotherapy and surgery for locally advanced esophageal cancer
Inks seven year contract for linacs, Gamma Knife and CyberKnife systems
Limiting kidney exposure while maximizing tumor treatment
Will help directly target and irradiate cancer cells
Will help track moving tumors and guide proton beam to spare healthy tissue